Heterogeneity of reports about the impact of the
            <scp>COVID</scp>
            ‐19 pandemic on melanoma diagnosis

Ricci, Francesco; Abeni, Damiano

doi:10.1111/bjd.21598

Cited by 7 publications

(11 citation statements)

References 11 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…2 Contrasting and variable effects of COVID-19 on skin melanoma have been reported in literature, 1,3-5 however, differences between our and authors' data may be explained by the different rules of restriction adopted among worldwide countries. 1,4 Indeed, although a general reduction of face-to-face visits was reported during lockdown period, the dermato-oncological section maintained the same activity levels than previous years, ensuring both follow-up and first visits for patients, thus avoiding the reduction of screening visits (except during the first lockdown period).…”

mentioning

confidence: 98%

Reply to ‘Impact of the French COVID‐19 pandemic lockdown on newly diagnosed melanoma delay and severity’ by R. Molinier et al.

Ruggiero

Fornaro

Scalvenzi

et al. 2022

Acad Dermatol Venereol

View full text Add to dashboard Cite

mentioning

confidence: 98%

Reply to ‘Impact of the French COVID‐19 pandemic lockdown on newly diagnosed melanoma delay and severity’ by R. Molinier et al.

Ruggiero

Fornaro

Scalvenzi

et al. 2022

Acad Dermatol Venereol

View full text Add to dashboard Cite

“…Our analysis of five studies analyzing changes in the proportion of melanoma diagnoses by stage during the pandemic revealed mixed findings. We observed reported increases and decreases in the proportions of melanoma stages 13 . Ricci and Abeni previously commented on conflicting results of studies describing the pandemic's impact on melanoma diagnosis, arguing that the small sample size of single‐institution studies has resulted in a heterogeneity of reported pandemic impacts to melanoma diagnosis.…”

Section: Discussionmentioning

confidence: 67%

“…We observed reported increases and decreases in the proportions of melanoma stages. 13 Ricci and Abeni previously commented on conflicting results of studies describing the pandemic's impact on melanoma diagnosis, arguing that the small sample size of single-institution studies has resulted in a heterogeneity of reported pandemic impacts to melanoma diagnosis. Our analysis of changes in proportions of melanoma staging reflects this observation and indicates that larger studies are needed to better characterize the pandemic's impact on melanoma tumor burden.…”

Section: Stagingmentioning

confidence: 99%

Impact of the COVID‐19 pandemic on melanoma diagnosis and presentation: a `review

2023

View full text Add to dashboard Cite

The ongoing challenges posed by COVID‐19 are concerning for their impact on successful detection and recognition of melanoma as total body skin examinations and skin biopsies are critical for identifying early‐stage melanoma and intervening before progression to metastatic disease. A comprehensive electronic search of PubMed/MEDLINE was conducted on or before August 1, 2022, using the search terms (“skin” AND “COVID‐19”), ([“skin cancer” AND “COVID‐19”] OR [“skin cancer” AND “coronavirus”]), ([“melanoma” AND “COVID‐19”] OR [“melanoma” AND “coronavirus”]), (“dermatology” AND “COVID‐19”), and (“cutaneous” AND “COVID‐19”). Eight articles representing Belgium, Chile, France, Germany, Spain, the United Kingdom, and the United States were included. Four articles analyzed changes in the proportion of in situ melanoma at diagnosis and consistently reported decreases, with an overall decrease ranging from 7.6 to 40.4%. Five studies analyzed changes in the proportion of melanoma diagnoses by staging, but no clear changes in staging patterns were observed. Five studies analyzed changes in the mean Breslow thickness of melanoma diagnoses and consistently reported increases, with an overall increase ranging from 4.0 to 38%. Disruptions to proper diagnosis and treatment of melanoma are creating undue morbidity, mortality, and healthcare costs as the pandemic continues. Continued research with improved, centralized data collection is needed to better address the COVID‐19 pandemic's ongoing challenge to appropriate detection and treatment of melanoma.

show abstract

“…The reduction in the number of melanoma diagnoses in 2020 (as compared with 2019) was minor and likely related to the COVID-19 pandemic. However, reports concerning the impact of COVID-19 in the number of annual melanoma diagnoses have been inconsistent [ 14 ].…”

Section: Discussionmentioning

confidence: 99%

Dermoscopy Use Leads to Earlier Cutaneous Melanoma Diagnosis in Terms of Invasiveness and Size? A Single-Center, Retrospective Experience

Nazzaro

Passoni

Pozzessere

et al. 2022

JCM

View full text Add to dashboard Cite

Background: The incidence of cutaneous melanoma has risen in recent years. The aim of this study was to compare cutaneous melanomas diagnosed at the Dermatology Unit of Fondazione IRCCS Ca’ Granda Ospedale Maggiore Policlinico, Milan, Italy, from 2006 to 2020 and between two specific biennia, i.e., 2006–2007 and 2019–2020. Methods: Retrospective chart review, with dermoscopic image collection, of cutaneous melanomas diagnosed at the Fondazione IRCCS Ca’ Granda Ospedale Maggiore Policlinico, Milan, Italy, from 1 January 2006 to 31 December 2020 Results: A statistically significant increase was shown in the proportions of in situ melanoma and melanoma measuring less than 6 mm, i.e., small-diameter melanoma (SDM), across the studied period (p < 0.001). Moreover, in the biennium 2006–2007, among 220 melanoma diagnoses, 6 were in situ (2.7%), as compared with 68 melanomas in situ out of a total of 236 (28.8%) melanomas diagnosed in the biennium 2019–2020. A statistically significant difference in the proportion of in situ melanoma between the two biennia was demonstrated (p < 0.001). Furthermore, during the first biennium, 27/220 (12.3%) SDM were identified, as compared with 61/236 (25.9%) in the last. A statistically significant difference was shown in the proportion of SDM between the two (p < 0.001). Conclusions: The percentage of in situ melanomas and those that can be detected at a diameter <6 mm has increased. The latter has been shown to be around one-third of excised lesions, thus undermining the practicality of the ABCD mnemonic. Dermoscopic criteria for SDM are needed to help further refine melanoma diagnosis.

show abstract

Heterogeneity of reports about the impact of the COVID ‐19 pandemic on melanoma diagnosis

Abstract: Linked Article: Sangers TE et al. Br J Dermatol 2022; 187 :196–202.

Cited by 7 publications

References 11 publications

Reply to ‘Impact of the French COVID‐19 pandemic lockdown on newly diagnosed melanoma delay and severity’ by R. Molinier et al.

Reply to ‘Impact of the French COVID‐19 pandemic lockdown on newly diagnosed melanoma delay and severity’ by R. Molinier et al.

Impact of the COVID‐19 pandemic on melanoma diagnosis and presentation: a `review

Dermoscopy Use Leads to Earlier Cutaneous Melanoma Diagnosis in Terms of Invasiveness and Size? A Single-Center, Retrospective Experience

Contact Info

Product

Resources

About